Importantly, when animals were treated with AOM alone, there was no effect on intestinal tumor burden, indicating DSS-induced intestinal inflammation is required to induce the phenotypical differences observed between Phd1–/– and control mice. The gene discussed is EGLN2; the disease is infectious otitis media.